These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6300871)

  • 1. Rescue of transforming Epstein-Barr virus (EBV) from EBV-genome-positive epithelial hybrid cells transfected with subgenomic fragments of EBV DNA.
    Stoerker J; Glaser R
    Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1726-9. PubMed ID: 6300871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a region of the Epstein-Barr virus (B95-8) genome required for transformation.
    Stoerker J; Holliday JE; Glaser R
    Virology; 1983 Aug; 129(1):199-206. PubMed ID: 6310878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.
    Rymo L; Klein G; Ricksten A
    Proc Natl Acad Sci U S A; 1985 May; 82(10):3435-9. PubMed ID: 2987926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.
    Wang F; Marchini A; Kieff E
    J Virol; 1991 Apr; 65(4):1701-9. PubMed ID: 1848303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus recombinants from overlapping cosmid fragments.
    Tomkinson B; Robertson E; Yalamanchili R; Longnecker R; Kieff E
    J Virol; 1993 Dec; 67(12):7298-306. PubMed ID: 8230453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer.
    Volsky DJ; Gross T; Sinangil F; Kuszynski C; Bartzatt R; Dambaugh T; Kieff E
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):5926-30. PubMed ID: 6091119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescue of a biologically active Epstein-Barr virus from nonproducer cells.
    Takimoto T; Sato H; Ogura H; Glaser R
    Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
    Glaser R; Tarr KL; Dangel AW
    Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional mapping of the Epstein-Barr virus genome: identification of sites coding for the restricted early antigen, the diffuse early antigen, and the nuclear antigen.
    Glaser R; Boyd A; Stoerker J; Holliday J
    Virology; 1983 Aug; 129(1):188-98. PubMed ID: 6310877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas.
    Yao KT; Zhang HY; Zhu HC; Wang FX; Li GY; Wen DS; Li YP; Tsai CH; Glaser R
    Int J Cancer; 1990 Jan; 45(1):83-9. PubMed ID: 2153642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Epstein-Barr virus genes expressed during the early phase of virus replication and during lymphocyte immortalization.
    Sample J; Tanaka A; Lancz G; Nonoyama M
    Virology; 1984 Nov; 139(1):1-10. PubMed ID: 6093376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.
    Takada K; Shimizu N; Sakuma S; Ono Y
    J Virol; 1986 Mar; 57(3):1016-22. PubMed ID: 3005608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three Epstein-Barr virus (EBV)-determined nuclear antigens induced by the BamHI E region of EBV DNA.
    Shimizu N; Yamaki M; Sakuma S; Ono Y; Takada K
    Int J Cancer; 1988 May; 41(5):744-51. PubMed ID: 2835324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
    Grogan E; Jenson H; Countryman J; Heston L; Gradoville L; Miller G
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1332-6. PubMed ID: 3029778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    King W; Thomas-Powell AL; Raab-Traub N; Hawke M; Kieff E
    J Virol; 1980 Nov; 36(2):506-18. PubMed ID: 6253674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping.
    Dambaugh T; Beisel C; Hummel M; King W; Fennewald S; Cheung A; Heller M; Raab-Traub N; Kieff E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2999-3003. PubMed ID: 6248879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction.
    Takimoto T; Iwawaki J; Tanaka S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiobiological inactivation of Epstein-Barr virus.
    Henderson E; Heston L; Grogan E; Miller G
    J Virol; 1978 Jan; 25(1):51-9. PubMed ID: 202757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.